James B. Yu, MD, MHS | Authors

POINT-Which Treatment Modality for Localized Prostate Cancer Yields Superior Quality of Life: Radiotherapy or Prostatectomy?

November 15, 2017

Quality of life is better after modern radiotherapy compared with surgery.

Chemoradiation Therapy for Organ Preservation in Localized Male Urethral Carcinoma

June 15, 2016

More research is needed to define the optimal radiotherapy and chemotherapy regimen for male urethral carcinoma. However, modern chemoradiation is a feasible treatment option for motivated men with urethral carcinoma who want to preserve their organs.

Breast Cancer Brain Metastases: One Step at a Time

July 15, 2014

For many women, the prospect of tumors growing in their brain that may eventually impact their ability to communicate, interact, and remember is terrifying.

Brain CT Scan Shows “Spoke Wheel” Pattern Following Concussion

May 12, 2014

A 62-year-old man trips on a curb and hits his head. He presents to the emergency department after a concussion, and a non-contrast CT of the head is obtained. What is the most likely diagnosis?

The Daily Miracle of Palliative Radiotherapy for Prostate Cancer

April 15, 2014

It is important for all of us now and then to take a step back and recapture the wonder that we all felt at the onset of our careers, when treatments we now consider simple and routine held an aura of miracle. For me, a little bit of that wonder returns every time I treat a patient with a bony metastasis-in particular, from prostate cancer.

Proton Radiotherapy for Prostate Cancer: How Did We Get Here, and Where Do We Go From Here?

December 15, 2013

Despite the promise of proton therapy, comparative evidence has yet to definitively demonstrate its clinical benefit over other forms of contemporary radiation for prostate cancer.

Introducing a New Resource for Readers of ONCOLOGY: The American College of Radiology Appropriateness Criteria

August 15, 2013

The ACR Appropriateness Criteria®, and their mission to improve the knowledge of practicing oncologists and the level of care our patients receive, is wholly consistent with the goals of ONCOLOGY. We are hopeful that our readership will find the ACR Appropriateness Criteria® a valuable resource in their day-to-day practice. I personally look forward to future guidelines in this series.